C4 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights Nov 6, 2025 07:00AM
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P. Oct 24, 2025 04:30PM
C4 Therapeutics prices $125 million stock offering Oct 16, 2025 07:08AM
C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering Oct 16, 2025 07:08AM
C4 Therapeutics Inc. (CCCC) Appoints Owen Hughes to its Board Nov 20, 2023 07:01AM


Nov 20, 2023 07:00AM C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment